440 filings
Page 8 of 22
UPLOAD
pnrgtass329da
17 Jun 20
Letter from SEC
12:00am
8-K
uv1e58fpj8fodh5ii9y
16 Jun 20
Departure of Directors or Certain Officers
5:27pm
S-8
8za14 l5r3ja
16 Jun 20
Registration of securities for employees
4:52pm
POS AM
9bsl5c iq
8 Jun 20
Prospectus update (post-effective amendment)
12:00am
8-K
05lbv hstx534gj1c2c
4 Jun 20
AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
4:05pm
8-K
ttr9f5r
29 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:12pm
425
eh19qq2qsp9ki
29 May 20
Business combination disclosure
5:10pm
425
rxcj9i6 eo9slegkl1
29 May 20
Business combination disclosure
8:54am
8-K
0x5qa7dd
27 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:03pm
425
2s97bw
27 May 20
Business combination disclosure
5:01pm
425
babjqv92wkebin
27 May 20
Business combination disclosure
9:29am
8-K
4to66ps 9yid6
22 May 20
Termination of a Material Definitive Agreement
4:11pm
425
5e493q 19
12 May 20
Business combination disclosure
4:10pm
425
y20f0haks9yx
11 May 20
Business combination disclosure
4:06pm
8-K
klonb1sas877f ob26bg
11 May 20
AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results
4:05pm
8-K
914y9z
30 Apr 20
AcelRx Announces DSUVIA® Milestone C Approval
8:24am
425
4y0746 ztjmxjf
30 Apr 20
Business combination disclosure
8:22am
EFFECT
6q2fr8 zv7ntskjpq8ty
27 Apr 20
Notice of effectiveness
12:15am